On November 13, Justice Brongers of the Supreme Court of British Columbia extended Vitasave Wellness Inc.'s stay of proceedings, which was to run out on November 20, "up to and including January 29, 2027," the date the company had asked for, per the Order Made After Application (Stay Extension Order), Nov. 13, 2026, para. 1 and the Notice of Application, Nov. 6, 2026, Part 1, para. 1. Bank of Montreal, which describes itself as Vitasave's senior secured lender, "owed more than $4.5 million," opposed the extension in an application response dated November 12 and stamped by the Vancouver registry on November 13. It consented to none of the orders the company sought and opposed both, per the BMO Application Response, Nov. 12, 2026, Parts 1–2 and Part 4, paras. 2, 5. No reasons or endorsement for the order are in the record.
The new date carries the company past the first deadline in its search for a bidder. On November 2 the monitor, Ernst & Young Inc., in consultation with the company, began a stalking horse solicitation process, inviting the seven parties that had made inbound inquiries since its appointment to take part. Letters of intent are due by 5:00 p.m. Pacific Standard Time on November 20, at a price that "should be not less than $8,100,000," and if a stalking horse bidder is selected, the company intends to seek the court's approval of an agreement with it in early January 2027, per the Second Report of the Monitor, Nov. 6, 2026, paras. 29, 31–32.
When the case was reported here on September 19, the amended and restated initial order of September 18 had just extended the stay to November 20 and let the company borrow up to $2.3 million under its interim facility from Fairway Ventures Corp., to restore products that had run out of stock and then rebuild the range it offers, per the fourth affidavit of Vitasave's director, Nov. 6, 2026, paras. 3, 5(a) and the Second Report of the Monitor, Nov. 6, 2026, paras. 2–3, 39(a).
The restock against its budget
The monitor's Second Report, dated November 6, measures the company's receipts and spending from September 12 to October 30 against the forecast attached to its First Report in September. Vitasave spent $539,126 on inventory against $1,094,000 budgeted, and drew $525,000 on the interim facility against $1,425,000. Receipts were $616,839 against $717,045, e-commerce coming in at $353,903 against $419,545 and the stores at $252,028 against $283,500. Net cash flow was negative $274,965, where the budget had been negative $939,244, and the period closed with $779,695 in cash against a forecast $1,015,416, per the Second Report of the Monitor, Nov. 6, 2026, paras. 7(c), 13–14.
The monitor puts the inventory shortfall primarily down to "the timing between the approval and submission of purchase orders and the delay related to the cash disbursement," and says it is also attributable to less buying than had been anticipated as necessary. The stores fell short, it says, on lower foot traffic in September. E-commerce trailed mainly on the timing of receipts from the Shopify and Amazon platforms, though that variance "may also be attributed to the cancellation of the Company's credit card, which resulted in a temporary interruption in online advertising for approximately one week." General and administrative costs and professional fees came in under budget, by the monitor's account, chiefly on the timing of payments and invoices, per the Second Report of the Monitor, Nov. 6, 2026, para. 15.
Since the filing, the buying has run through the monitor. Each purchase order, the company's sole director affirmed on November 6, is prepared product by product from recent demand for that product and submitted to the monitor for approval before it is placed. The company built a purchase order tracker, linked to its inventory system, that records each order "from approval through delivery and payment," and the monitor has a read-only copy that updates every 30 minutes through the business day, per the fourth affidavit of Vitasave's director, Nov. 6, 2026, paras. 1, 5(a). The monitor, for its part, says that in reviewing each proposed order it considers, among other things, the company's liquidity, per the Second Report of the Monitor, Nov. 6, 2026, para. 24.
A forecast that draws the rest of the facility
Vitasave will have sufficient liquidity to cover its expenses during the extension, its director says, based on a revised cash flow forecast, per the fourth affidavit of Vitasave's director, Nov. 6, 2026, para. 8. The company prepared that third forecast in consultation with the monitor for the thirteen weeks ending January 29, 2027. In Canadian dollars, it projects receipts of $1,354,191 against inventory purchases of $1,810,607 and net cash flow of negative $1,721,325. The company intends to draw the remaining $1,400,000 of the interim facility over the period, leaving an estimated $458,371 at the end, which "is expected to be used to further stabilize inventory as purchases are made and fund operations should the Stay Period be extended beyond the Second Report Forecast Period," per the Second Report of the Monitor, Nov. 6, 2026, paras. 7(d), 16–17, 19(g)–(h).
The money comes in through the company's e-commerce platforms, primarily its Shopify and Amazon stores, and its two shops, at 551 Robson Street in Vancouver and in North Vancouver. Receipts rise from $84,927 in the week ending November 6 to $147,536 in the week ending January 29, which the forecast's assumptions tie to increased inventory balances, with store sales forecast to dip over the weeks ending December 25 and January 1 for the holidays. Net cash flow is negative in every week but the one ending January 22, at $13,135. The draws fall in four instalments of $300,000, in the weeks ending November 13, November 27, December 4 and December 18, and one of $200,000 in the week ending January 1. In the note on those draws, "It is assumed that interest and fees will be capitalized," per the Second Report of the Monitor, Nov. 6, 2026, para. 19(a) and App. "A", notes 1–2, 12.
The forecast assumes the company completes its inventory replenishment plan in the period and begins preparing for a potential sale process. The company has told the monitor that its optimal inventory has a cost base of $2,100,000, the level at which it expects "to be operationally cash flow positive," and that it expects to have substantially reached it by approximately the week ending January 8, 2027, per the Second Report of the Monitor, Nov. 6, 2026, paras. 19(i), 26.
Seven inquiries and an $8.1 million floor
Since its appointment, the monitor says, it has received seven inbound inquiries from parties interested in a transaction involving the company's assets and operations, "certain of whom indicated a potential interest in submitting an initial bid that would serve as a benchmark for competing bids." On October 27 it asked the company to compile diligence materials for a virtual data room, and, in connection with the process that began on November 2, it sent each of the seven an invitation letter and a non-disclosure agreement, per the Second Report of the Monitor, Nov. 6, 2026, paras. 29–31.
Keep reading with a 5-day free trial
About 5 more minutes of this analysis, and 2 more sections. Every fact in it cites the filing it was read from.
Card required. Nothing charged for 5 days. Cancel anytime.
Already a subscriber? Sign in.
See all plans